Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report

Congenital generalized lipodystrophy type 4 (CGL4) is a rare disease caused by mutations in the gene polymerase I and transcript release factor (PTRF), the main symptoms of which are systemic reductions in adipose tissue and muscular dystrophy. The strategy of treating CGL4 is to improve the insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeyari, Shinji, Takakuwa, Satoshi, Miyata, Kei, Yamamoto, Kenichi, Nakayama, Hirofumi, Ohata, Yasuhisa, Fujiwara, Makoto, Kitaoka, Taichi, Kubota, Takuo, Namba, Noriyuki, Sakai, Norio, Ozono, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356095/
https://www.ncbi.nlm.nih.gov/pubmed/30745727
http://dx.doi.org/10.1297/cpe.28.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356095/
https://www.ncbi.nlm.nih.gov/pubmed/30745727
http://dx.doi.org/10.1297/cpe.28.1

Ejemplares similares